IRCT20141025019669N13招募中3 期
Assessment the ellagic acid supplementation effect on glycemic status, insulin resistance, inflammatory factors, antioxidant status and expression of miR146-a in patients with type 2 diabetes: double blind randomized clinical trial
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 24 years 至 55 years（—）
- 性别
- All
入选标准
- •Men and women with with type 2 diabetes
- •Willingness to work
- •Age 25- 55
- •Non-modification of treatment and medications for at least the past 2 months
- •Moderate physical activity
排除标准
- •Insulin using
- •Having diabetes for more than ten years
- •Pregnancy and breastfeeding
- •Patients with severe renal and hepatic dysfunction,
- •Alcohol consumption
研究者
相似试验
招募中
3 期
Ellagic acid supplementation effect in patients with Major DepressiveMajor depressive episode.Major depressive disorder, single episodeIRCT20141025019669N15Mazandaran University of Medical Sciences60
已完成
3 期
Ellagic acid supplementation in women with the poly cystic ovarian syndromePolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20141025019669N12Qazvin University of Medical Sciences60
招募中
3 期
Ellagic acid supplementation in patients with non-alcoholic fatty liver diseaseon alcoholic fatty liver disease.Other specified inflammatory liver diseasesK75.8IRCT20141025019669N21Qazvin University of Medical Sciences44
已完成
3 期
Ellagic acid supplementation in patient with irritabe bowel syndromeIrritable bowel syndrome.K58.0Irritable bowel syndrome with diarrheaIRCT20141025019669N11Qazvin University of Medical Sciences44
尚未招募
3 期
Ellagic acid in multiple sclerosisMultiple sclerosisIRCT20120415009472N22Iran University of Medical Sciences46